Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Sep 27, 2019 at 9:55 AM EDT

Good News for Teens Suffering Atopic Dermatitis

Pfizer has announced positive top-line results from a second Phase 3 pivotal study evaluating abrocitinib, in patients aged 12 and…

John Harrington | Sep 27, 2019 at 8:31 AM EDT

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Between 2009 and 2017, the percentage of American children and teens aged 3 to 17 who were diagnosed with developmental…

Chris Lange | Sep 26, 2019 at 10:30 AM EDT

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Enanta Pharma shares dropped on Thursday after the company announced topline results from its Argon-1 Phase 2a study of EDP-305…

Paul Ausick | Sep 25, 2019 at 3:54 PM EDT

Has Amazon Bigfooted Teladoc?

Amazon has launched a telemedicine smartphone app for some Seattle-based employees. The news dented Teladoc's share price, but not as…

John Harrington | Sep 25, 2019 at 11:58 AM EDT

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Green tea has long been hailed for a variety of health benefits. Among other things, it is said to improve…

Chris Lange | Sep 25, 2019 at 11:40 AM EDT

Achillion Pharma Wins Big With FDA Breakthrough

Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan…

Chris Lange | Sep 25, 2019 at 10:10 AM EDT

Why This Cardiopulmonary Trial Is a Big Hit

PhaseBio Pharma shares jumped on Wednesday after the firm announced results from its midstage trial focused on novel therapies for…

Chris Lange | Sep 25, 2019 at 9:30 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 24, 2019 at 10:25 AM EDT

Why This Colorectal Cancer Treatment Approval Is a Big Hit

One analyst sees FDA approval of its noninvasive colorectal cancer screening test tacking on another 30% to Exact Sciences stock.

Chris Lange | Sep 23, 2019 at 3:29 PM EDT

Viela Bio Gears Up For IPO

Viela Bio filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its IPO. The company…

Chris Lange | Sep 23, 2019 at 12:10 PM EDT

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

Acadia shares made a handy gain on Monday after the firm announced positive results from an eight-week Phase 2 study…

Chris Lange | Sep 23, 2019 at 11:53 AM EDT

Major Biotechs Scare Off Short Sellers

The September 13 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 23, 2019 at 10:00 AM EDT

Why This Late-Stage Narcolepsy Study Is Way Ahead of Schedule

Avadel Pharma shares jumped on Monday morning after the firm announced that the FDA has agreed to the company’s proposed…

Chris Lange | Sep 21, 2019 at 11:26 AM EDT

7 Biotechs With Catalysts in the Next Month

Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

1 … 83 84 85 86 87 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Good News for Teens Suffering Atopic Dermatitis

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Has Amazon Bigfooted Teladoc?

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Achillion Pharma Wins Big With FDA Breakthrough

Why This Cardiopulmonary Trial Is a Big Hit

Major Biotechs Scare Off Short Sellers

Short Sellers Grow More Selective in Big Pharma

Why This Colorectal Cancer Treatment Approval Is a Big Hit

Viela Bio Gears Up For IPO

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

Major Biotechs Scare Off Short Sellers

Why This Late-Stage Narcolepsy Study Is Way Ahead of Schedule

7 Biotechs With Catalysts in the Next Month

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Good News for Teens Suffering Atopic Dermatitis

Rates of Autism and ADHD Are Increasing Significantly for U.S. Kids

Is This Trial Really Disappointing News for Non-Alcoholic Steatohepatitis Sufferers?

Has Amazon Bigfooted Teladoc?

Green Tea Could Hold the Answer to Reducing Drug Resistant Bacteria

Achillion Pharma Wins Big With FDA Breakthrough

Why This Cardiopulmonary Trial Is a Big Hit

Major Biotechs Scare Off Short Sellers

Short Sellers Grow More Selective in Big Pharma

Why This Colorectal Cancer Treatment Approval Is a Big Hit

Viela Bio Gears Up For IPO

Why Parkinson’s Patients Should Be Optimistic About Acadia’s Study

Major Biotechs Scare Off Short Sellers

Why This Late-Stage Narcolepsy Study Is Way Ahead of Schedule

7 Biotechs With Catalysts in the Next Month

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up